Detalhe da pesquisa
1.
TGFß-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma.
EMBO Rep
; 25(3): 1022-1054, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332153
2.
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes.
Hum Mol Genet
; 32(16): 2646-2655, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369012
3.
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma.
Gastroenterology
; 166(5): 886-901.e7, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096955
4.
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
Hepatology
; 79(2): 269-288, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535809
5.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology
; 79(1): 135-148, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505221
6.
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Hepatology
; 78(6): 1742-1754, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789652
7.
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Hepatology
; 78(3): 709-726, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999529
8.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
FASEB J
; 37(11): e23220, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801035
9.
aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; : 502207, 2024 May 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723772
10.
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.
J Hepatol
; 78(2): 364-375, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848245
11.
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
J Hepatol
; 79(1): 93-108, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868481
12.
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids.
Hepatology
; 76(6): 1617-1633, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030285
13.
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.
Hepatology
; 76(4): 1121-1134, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220605
14.
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Liver Int
; 43(10): 2256-2274, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534739
15.
Polycystic liver diseases: from molecular basis to development of effective treatments.
Rev Esp Enferm Dig
; 115(10): 542-545, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114427
16.
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
Gut
; 71(8): 1669-1683, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580963
17.
Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex.
J Hepatol
; 76(4): 921-933, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953958
18.
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.
J Hepatol
; 77(4): 991-1004, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750136
19.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
J Hepatol
; 77(1): 177-190, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217064
20.
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
J Hepatol
; 76(5): 1109-1121, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167909